XRTX
XORTX Therapeutics Inc.
2.12
2 x 1.57
2 x 2.76
bid
ask
-
0.05
2.30%
2 @ 07:07 AM
2.24 +0.12 (5.50%)
| Ytd | -24.56% | |
| 1y | -52.47% |
2.12
day range
2.15
1.73
52 week range
7.05
| Open | 2.14 | Prev Close | 2.17 | Low | 2.12 | High | 2.15 | Mkt Cap | 3.67M |
| Vol | 9.65K | Avg Vol | 1.28M | EPS | -2.45 | P/E | N/A | Forward P/E | -0.67 |
| Beta | -0.21 | Short Ratio | 0.02 | Inst. Own | 6.03% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-13 | 50-d Avg | 2.41 | 200-d Avg | 2.78 | 1yr Est | 12.17 |
| Income Statement | |||
| Operating Expenses | 823.30K | ||
| Research and Development Expense | 33.11K | ||
| Selling, General and Administrative Expense | 248.75K | ||
| Operating Income | -823.30K | ||
| Net Income | -808.47K | ||
| Net Income Common Stock | -808.47K | ||
| Net Income Common Stock (USD) | -585.85K | ||
| Consolidated Income | -808.47K | ||
| Earnings per Basic Share | -0.58 | ||
| Earnings per Basic Share (USD) | -0.42 | ||
| Earnings per Diluted Share | -0.58 | ||
| Earning Before Interest & Taxes (EBIT) | -808.47K | ||
| Earning Before Interest & Taxes (USD) | -585.85K | ||
| Weighted Average Shares | 1.39M | ||
| Weighted Average Shares Diluted | 1.39M | ||
| Balance Sheet | |||
| Cash and Equivalents | 250.28K | ||
| Cash and Equivalents (USD) | 181.36K | ||
| Trade and Non-Trade Receivables | 64.63K | ||
| Current Assets | 744.42K | ||
| Property, Plant & Equipment Net | 14.68K | ||
| Total Assets | 2.14M | ||
| Debt Current | 15.06K | ||
| Total Debt | 15.06K | ||
| Current Liabilities | 860.99K | ||
| Total Liabilities | 860.99K | ||
| Accumulated Retained Earnings (Deficit) | -24.63M | ||
| Accumulated Other Comprehensive Income | -52.60K | ||
| Shareholders Equity | 1.28M | ||
| Shareholders Equity (USD) | 930.29K | ||
| Assets Non-Current | 1.40M | ||
| Total Debt (USD) | 10.91K | ||
| Goodwill and Intangible Assets | 185.70K | ||
| Trade and Non-Trade Payables | 844.93K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 25.85K | ||
| Net Cash Flow from Financing | -104.20K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -614.24K | ||
| Issuance (Repayment) of Debt Securities | -22.23K | ||
| Net Cash Flow from Investing | -7.91K | ||
| Net Cash Flow from Operations | -501.36K | ||
| Effect of Exchange Rate Changes on Cash | -763.00 | ||
| Share Based Compensation | 7.82K | ||